A diagnostic tool designed for the detection of human chorionic gonadotropin in urine. This immunoassay provides a rapid visual result, indicating the presence or absence of the hormone associated with pregnancy. The convenience lies in its streamlined procedure, typically requiring only a single application of urine to the testing device.
The simplicity of these assays makes them widely accessible and user-friendly, allowing individuals to obtain preliminary results in the privacy of their homes. Their development represents a significant advancement in personal healthcare management, offering early confirmation that can influence timely medical care and informed decision-making regarding reproductive health. Historically, laboratory testing was the primary method for pregnancy confirmation, so these types of rapid tests provided a more convenient option.